Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Invasive
Interventions: DRUG: Pyrotinib|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Nab-paclitaxel|DRUG: EC chemotherapy|DRUG: Physician's choice|DRUG: T-DM1|PROCEDURE: Surgery
Sponsor: Shanghai Jiao Tong University School of Medicine
Collaborators: Jiangsu HengRui Medicine Co., Ltd.